Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-62.27	27.23	72.18
Graham Fair Price	41.52	0.28	0.20
PEG	-37.97	3.88	-6.25
Price/Book	26.36	0.44	0.35
Price/Cash Flow	1981.53	528.40	25.39
Prices/Earnings	-36.82	387.66	613.59
Price/Sales	-36.82	1.67	2.64
Price/FCF	1981.53	528.40	25.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.49	0.49
Operating Margin	932.03	-0.07	< 0.005
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	916.26
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.04	-0.03	39.18
Dividends QOQ	-0.20	< 0.005	-99.65
EBIT QOQ	1.85	-21.64	1071.42
EPS QOQ	-0.98	1.00	1.86
FCF QOQ	1.59	-0.94	-40.93
Revenue QOQ	-0.47	1.00	111.75
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	195.92	97.96	-50.00
Days Sales Outstanding (DSO)	28.16	21.64	-23.16
Inventory Turnover	0.46	0.92	100.00
Debt/Capitalization	0.09	0.09	1.63
Quick Ratio	0.39	0.47	18.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3.46	3.46	0.07
Cash	0.29	0.29	1.35
Capex	-0.01	-0.12	-884.92
Free Cash Flow	0.05	< 0.005	-93.93
Revenue	0.46	0.92	100.14
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.01	1.01	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.51	0.90	-63.97
Naive Interpretation	Member

06 - Financial Health · Bad

Rating